Skip to main content
. Author manuscript; available in PMC: 2020 Oct 12.
Published in final edited form as: Lancet Glob Health. 2020 Sep;8(9):e1223–e1233. doi: 10.1016/S2214-109X(20)30227-8

Figure 4: Cost-effectiveness analysis of modelled interventions.

Figure 4:

(A) Expected incremental net monetary benefit of each strategy with respect to the base-case strategy (for a given cost-effectiveness threshold, the optimal strategy is the one with the highest expected incremental net monetary benefit). (B) Probability that a strategy results in the highest net monetary benefit for various cost-effectiveness thresholds. IPT=isoniazid preventive therapy. DALY=disability-adjusted life-year.